Can You Live Normally With Chronic Hepatitis B? Alcohol, Work, Exercise and Check-Ups

The letter arrives on a Tuesday. A routine blood donation, a screening before a new job, a prenatal panel: the reason varies, but the sentence is the same: hepatitis B surface antigen, positive, likely chronic. Many people read it twice, then open a search engine and type the one question that actually matters to them: can I still have my life?

The honest answer is more reassuring than the internet’s loudest voices suggest, and more nuanced than a shrug. Living with chronic hepatitis B is, for most people, a story of surveillance rather than symptoms. The virus tends to sit quietly for years. What determines the long-term outcome is not how you feel but what shows up in a handful of blood tests and an ultrasound scan, repeated at intervals your care team sets.

This explainer walks through the questions people ask in the days after that letter: alcohol, work, exercise, food, sex, pregnancy, tablets, and the check-up schedule that quietly holds everything together.

What living with chronic hepatitis B actually means inside the liver

Hepatitis B is a virus that infects liver cells. When an adult catches it, the immune system usually clears the infection within months. When it does not, and the virus is still detectable after six months, the infection is called chronic. The World Health Organization estimates that roughly 254 million people worldwide are living with chronic hepatitis B, most of them infected at birth or in early childhood.

Age at infection largely decides who develops chronic disease. According to the CDC, about 90% of infants infected at birth develop chronic infection, compared with 25% to 50% of children infected between ages one and five, and only around 5% of adults. That is why so many people discover their diagnosis decades after the event, with no memory of ever being ill.

The virus itself does very little direct damage. Most liver injury comes from the immune system attacking infected cells, year after year. Doctors describe this with a few key measurements. HBV DNA is the amount of virus circulating in the blood. ALT (alanine aminotransferase) is a liver enzyme that leaks into the bloodstream when liver cells are injured. HBeAg (hepatitis B e antigen) is a protein that, when present, usually signals active viral replication. Together, these place a person in one of several phases: high virus but a quiet immune system; active inflammation; a low-virus, low-inflammation state often called inactive; or a later phase where the virus mutates and inflammation returns.

People move between phases over a lifetime, which is the whole rationale for check-ups. A quiet liver today is not a guarantee of a quiet liver in ten years, and a flare can pass unnoticed unless someone is measuring.

How bad is chronic hepatitis B? The honest spectrum

Chronic hepatitis B is neither trivial nor a sentence. It is a spectrum, and where a person sits on it depends on viral activity, liver inflammation, co-existing conditions and, to a large degree, whether they are being monitored.

At one end are people with low viral levels, normal enzymes and no scarring, who may go their whole lives without liver damage. At the other end are people whose years of inflammation have led to fibrosis, the build-up of scar tissue in the liver, and eventually cirrhosis, where scarring is extensive enough to stiffen the organ and disrupt its work. Cirrhosis raises the risk of liver failure and hepatocellular carcinoma, the most common form of primary liver cancer. Hepatitis B can also cause liver cancer without cirrhosis, which sets it apart from many other liver conditions and is why scans are recommended even for some people with otherwise healthy-looking livers.

The CDC estimates that between 15% and 25% of people with chronic hepatitis B develop serious liver disease over their lifetime if the infection is not identified and managed. Read that figure both ways: the majority never reach that point, and the minority who do are often people who were never tested or lost to follow-up.

Symptoms are a poor guide. Fatigue is common but nonspecific. Jaundice, swelling and confusion appear late. Mayo Clinic notes that many people with chronic infection feel entirely well until complications develop. This is uncomfortable to hear, but it points to a practical truth: the seriousness of hepatitis B is largely determined by whether it is watched. A person on a regular monitoring schedule has caught the disease at its most manageable point.

How long can you live with hepatitis B? What hepatitis B life expectancy really depends on

No responsible clinician can give a single number, and any article that does is guessing. The reasons are worth spelling out, because they double as a to-do list.

Life expectancy with chronic hepatitis B is shaped by a few measurable things. First, whether the liver has already scarred: someone with no fibrosis at diagnosis is in a very different position from someone with cirrhosis. Second, whether viral replication is controlled, either by the immune system or by antiviral medication. Third, whether liver cancer is caught early through routine ultrasound scans, since small tumors are treated very differently from large ones. Fourth, the presence of accelerants: alcohol, obesity-related fatty liver disease, hepatitis C or hepatitis D co-infection, and HIV.

For people who are monitored, treated when guidelines indicate, and who avoid the accelerants, the NHS and CDC both describe a condition that is managed long-term rather than one that shortens life. Antiviral medicines suppress the virus in the vast majority of people who take them consistently, and long-term suppression is associated with lower rates of cirrhosis and liver cancer in the guideline literature. That is a statement about risk reduction, not a promise for any one person.

Hepatitis D deserves a specific mention. It is a separate virus that can only infect people who already have hepatitis B, and it accelerates liver damage considerably. The WHO recommends testing for it in people with chronic hepatitis B; ask whether that has been done.

The question underneath the question is usually fear. It helps to reframe: the aim is not to predict a lifespan but to remove the factors that shorten it, most of which are within reach.

Who is usually offered chronic hepatitis B treatment, and who is asked to wait

One of the most confusing moments after diagnosis is being told you have a chronic viral infection and then being told you do not need medication yet. It feels like neglect. It is not.

Antiviral treatment for hepatitis B belongs to a class called nucleos(t)ide analogues; the generic names most often mentioned are tenofovir and entecavir. These work by blocking the enzyme the virus uses to copy its genetic material, so viral levels in the blood fall and the immune system stops attacking infected cells. They are taken as a daily tablet, usually for years and often indefinitely, because they suppress the virus rather than remove it. A second, older option, pegylated interferon, is an injection given for a defined period that boosts the immune response; it suits a smaller group and has more side effects.

Clinicians generally start treatment when the balance tips toward ongoing liver injury: high viral levels combined with raised ALT, evidence of significant fibrosis or cirrhosis on scans or blood-based scoring, a family history of liver cancer, or certain situations such as pregnancy with a very high viral load, immunosuppression or hepatitis D co-infection. The exact thresholds come from liver society guidelines and are applied to the individual.

People are asked to wait when the virus is present but the liver shows little inflammation and no scarring, because treatment offers little benefit while the immune system is not attacking, and because starting means committing to years of tablets. Waiting is active: it means blood tests and scans on a fixed schedule so that any shift is caught.

Two non-negotiables sit with the prescribing team. Only they decide when to start. And nobody should stop a hepatitis B antiviral on their own, because abrupt withdrawal can trigger a severe flare of liver inflammation.

Hepatitis B and alcohol: is there a safe amount?

This is the question people most want a lenient answer to, and the evidence does not give one. The NHS advises people with hepatitis B to avoid alcohol; Mayo Clinic and the CDC give the same guidance. The reasoning is mechanistic rather than moralistic.

Alcohol is metabolized almost entirely by the liver, and its breakdown products directly injure liver cells and promote scarring. In a liver already under immune attack, that is two sources of damage working in the same tissue. Studies summarized in guideline literature consistently find that people with chronic hepatitis B who drink heavily develop cirrhosis and liver cancer at higher rates and at younger ages than those who do not. Heavy drinking is the clearest finding. Whether light, occasional drinking carries measurable risk is less certain, and honesty requires saying so: the data are weaker at the low end, which is different from saying low intake is proven safe.

How to translate that into a life? Most hepatologists frame it this way: no amount of alcohol benefits a liver with hepatitis B, the safest choice is none, and the risk rises steeply with quantity and frequency. Someone with cirrhosis, or with raised ALT, is generally advised to abstain completely. Someone in an inactive phase with a healthy liver may have a more individualized conversation with their team.

Practical points that make abstaining easier: alcohol-free versions of beer and wine are now widely available; telling one trusted friend removes the pressure of explaining at every gathering; and a simple “I’m not drinking at the moment” needs no medical footnote. If cutting down feels difficult, say so at a check-up. Alcohol dependence is treatable, and liver teams raise it without judgment.

Can you work with hepatitis B? Jobs, disclosure and colleagues

For almost every occupation, chronic hepatitis B has no bearing on the ability to do the job. The virus is not spread by coughing, sneezing, shared cups, handshakes, shared bathrooms or shared workspaces. The CDC is explicit that casual contact in offices, schools and factories carries no risk.

Hepatitis B spreads through blood and certain body fluids, so questions arise mainly in jobs involving exposure-prone procedures: surgery, dentistry, some nursing roles, tattooing and piercing. Even here, blanket exclusion is not the norm. In the United States, CDC guidance states that hepatitis B infection alone should not disqualify a healthcare worker from practice; instead, workers performing exposure-prone procedures are typically monitored, and low viral levels, often achieved with antivirals, allow continued work under an expert review panel. Other countries have their own occupational health frameworks, which is why a person in one of these roles should speak with occupational health rather than rely on general articles.

Disclosure is a frequent worry. In most workplaces, there is no obligation to tell an employer, and in the United States chronic hepatitis B is generally recognized as a condition protected under federal disability discrimination law, according to the CDC. Colleagues do not need to know. Managers do not need to know. The exceptions are roles where occupational health screening is a formal requirement, and even then the information stays with the health service, not the line manager.

Fatigue is the one symptom that sometimes intersects with work, particularly during flares or when starting treatment. It tends to be intermittent. If tiredness is persistent enough to affect performance, mention it at a check-up: it may point to a change in liver activity, to a co-existing issue such as anemia or sleep problems, or to the emotional weight of the diagnosis, all of which have their own responses.

Exercise and sport with chronic hepatitis B

There is no exercise restriction for chronic hepatitis B in any major guideline. The liver is not a muscle you can overwork, and physical activity does not raise viral levels or drive inflammation. If anything, the case for exercise is stronger than average.

The mechanism runs through fat. Metabolic dysfunction-associated steatotic liver disease, the newer name for fatty liver disease linked to weight and insulin resistance, is increasingly common alongside hepatitis B, and the two conditions compound each other’s scarring risk. Regular aerobic activity and resistance training reduce liver fat, improve insulin sensitivity and lower the cardiovascular risk that ultimately affects many people with chronic liver disease. The American Heart Association’s general recommendation of at least 150 minutes of moderate activity a week is a reasonable target for people with hepatitis B who have no other limiting condition.

Contact sports raise a specific question about bleeding. The realistic risk of transmitting hepatitis B on a rugby pitch or in a boxing ring is low but not zero, since the virus is present in blood and can survive on surfaces for at least seven days according to the CDC. Standard sports hygiene covers it: cover cuts promptly, do not share razors or towels, and follow the blood-rule protocols that most leagues already have. Athletes are not required to disclose, though many choose to tell a team physician confidentially.

Two situations call for a conversation with the care team before pushing hard. During an acute flare, when ALT is markedly raised and fatigue is heavy, most clinicians suggest scaling back and listening to the body. And with established cirrhosis, especially with fluid in the abdomen or low platelets, strenuous or high-impact activity may need tailoring. Otherwise, the advice is the same one given to everybody: move most days, mix cardio with strength work, and enjoy it enough to keep going.

What foods should someone with hepatitis B eat? The hepatitis B diet, minus the myths

There is no special hepatitis B diet, and anyone selling one is selling. The liver does not need cleansing, detoxing or a particular superfood. What it needs is the same pattern that protects the heart and the pancreas, because the biggest dietary threat to a liver with hepatitis B is not a toxin but excess fat stored inside it.

The pattern that guideline bodies point to is recognizable: vegetables, fruit, whole grains, legumes, nuts, fish, lean protein and unsaturated oils, with limited sugary drinks, refined carbohydrates and ultra-processed foods. Coffee, unusually, has consistent observational data suggesting lower rates of liver fibrosis and liver cancer among regular drinkers, though this is an association rather than a proven protective effect, and nobody should start drinking coffee as treatment.

A few specific cautions are grounded in evidence rather than folklore:

• Raw or undercooked shellfish carries a risk of Vibrio vulnificus, a bacterium that can cause life-threatening infection in people with liver disease; the CDC advises those with liver conditions to avoid it.
• Herbal and “liver support” supplements are a documented cause of drug-induced liver injury. Green tea extract in concentrated form, kava, comfrey and some bodybuilding products appear repeatedly in case reports collected by the NIH. Tell your team about every supplement, including ones labeled natural.
• High-dose vitamin A is stored in the liver and can be harmful in excess; a standard multivitamin is a different matter, but ask.
• Over-the-counter painkillers are generally usable within label limits, though people with cirrhosis are given individualized advice, particularly about anti-inflammatory drugs.

Salt matters mainly for people with cirrhosis and fluid retention, where restriction is often advised. For everyone else, ordinary moderation is enough. The single most useful dietary act for most people with chronic hepatitis B is maintaining a healthy weight, because the combination of viral hepatitis and fatty liver accelerates scarring far more than either alone.

Sex, relationships and protecting the people you live with

Hepatitis B is transmitted through blood, semen and vaginal fluids, and through birth. It is not transmitted by kissing, hugging, sharing food or utensils, breastfeeding, or living in the same house, according to the CDC. Those facts should reshape the household conversation from fear to a short practical list.

The list starts with vaccination. The hepatitis B vaccine is highly effective and has been given for decades; every sexual partner and household member of a person with chronic hepatitis B should be tested and, if not already immune, vaccinated, per CDC guidance. Once a partner has completed the vaccine course and blood tests confirm immunity, the risk of transmission through sex is essentially removed, and many couples then make their own decisions about condom use with their clinician’s input. Until immunity is confirmed, condoms are advised.

Within the home, the rules are about blood, not proximity. Do not share razors, toothbrushes, nail clippers or glucose-testing lancets. Cover cuts. Clean blood spills with household bleach diluted in water, since the virus can survive on surfaces for at least seven days. Bandaged children can play with other children. Shared meals, shared beds, shared bathrooms are fine.

Telling a new partner is one of the harder parts of the diagnosis, and there is no script that removes the awkwardness. What helps is having the facts ready: that the vaccine exists, that it works, that transmission is preventable, and that millions of people are in the same position. Sexual health clinics can arrange partner testing and vaccination confidentially.

Blood and organ donation are the one area where status changes the rules: people with chronic hepatitis B are not eligible to donate blood. Tattoos and piercings are fine to receive at licensed studios that use sterile, single-use equipment, which is the standard anyone should insist on regardless of hepatitis status.

Everyday life with chronic hepatitis B: what the evidence says at a glance

Most of the questions in the first weeks after diagnosis have short, well-supported answers. The table below gathers them, with the reasoning behind each, so that a person can carry the summary into conversations with family, employers and partners. Every row reflects CDC, NHS and Mayo Clinic guidance and can be checked against the references at the end.

Everyday question	What the evidence supports	Why
Alcohol	Avoid, or keep to a minimum agreed with your team	Alcohol and viral inflammation both scar the liver; risk rises with amount
Work	No restriction for nearly all jobs; exposure-prone healthcare roles follow occupational health review	Virus spreads by blood and sexual fluids, not casual contact
Exercise and sport	Unrestricted; aim for the general adult activity target	Reduces liver fat and cardiovascular risk; no effect on viral activity
Diet	Balanced pattern, healthy weight; avoid raw shellfish and unvetted herbal supplements	Fatty liver compounds scarring; Vibrio and herbal liver injury are documented risks
Sex	Partner tested and vaccinated; condoms until immunity confirmed	Vaccine prevents transmission
Sharing meals, hugging, kissing	Completely fine	Not a route of transmission
Razors, toothbrushes, clippers	Do not share	May carry traces of blood
Pregnancy and breastfeeding	Both possible; birth-dose vaccine and immune globulin for the baby	Transmission at birth is preventable; breastfeeding is safe
Blood donation	Not eligible	Screening rules for blood supply
Tattoos and piercings	Fine at licensed studios using single-use equipment	Standard infection control protects everyone

The pattern in that table is worth noticing. Nearly every “restriction” is either an ordinary good habit that applies to everyone, or a one-time task such as vaccinating a partner. The genuinely hepatitis-specific work is the check-up schedule, which is where the next section goes.

Check-ups for chronic hepatitis B: what the following months and years usually look like

Monitoring is the spine of living with chronic hepatitis B. Everything else in this article is supporting structure. Here is what the routine typically involves, with the caveat that individual schedules vary and are set by the treating team.

After diagnosis, the first visit usually establishes a baseline: HBV DNA, ALT and other liver enzymes, HBeAg status, a full blood count, tests for hepatitis C, hepatitis D and HIV, and an assessment of scarring. Scarring is increasingly measured without a needle, using blood-based scores or a specialized ultrasound called elastography that gauges liver stiffness. A liver biopsy, where a small sample of tissue is taken, is now reserved for unclear cases.

From there, the rhythm settles. For people not on treatment, the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases describes regular blood tests, typically every six to twelve months, to detect a shift from a quiet phase to an active one. For people on antivirals, blood tests confirm the virus is suppressed and check kidney function, since some nucleos(t)ide analogues are cleared by the kidneys.

Liver cancer surveillance runs on its own track. Guideline groups summarized by the CDC recommend an abdominal ultrasound, sometimes with a blood marker called alpha-fetoprotein, roughly every six months for people at higher risk: those with cirrhosis, a family history of liver cancer, certain ancestry groups with higher background rates, and men and women above age thresholds that the guidelines specify. Six months is chosen because it matches how quickly small liver tumors tend to grow.

Between visits, life is ordinary. Most people describe the pattern as a twice-yearly appointment they build the calendar around, a phone call with results, and then months in which hepatitis B rarely crosses their mind. Missing appointments is the most common way the disease regains ground, so a reminder system, whether an app or a relative who nags, is a genuine medical intervention.

Pregnancy, children and hepatitis B: a preventable chain

Because most chronic hepatitis B worldwide begins at birth, pregnancy is where the biggest single opportunity to break the chain sits. The news here is good and specific.

Every pregnant person is offered a hepatitis B test as part of routine prenatal care in most countries, including the United States and the United Kingdom. When the test is positive, the plan for the baby is well established: a first dose of hepatitis B vaccine within hours of birth, together with hepatitis B immune globulin, a preparation of ready-made antibodies that provides immediate protection while the vaccine takes effect. The full vaccine series follows over the first months of life, and the baby is tested afterward to confirm immunity. The CDC describes this combined approach as highly effective at preventing transmission.

For pregnant people with very high viral levels, clinicians often discuss starting an antiviral in the later part of pregnancy to lower the amount of virus the baby is exposed to at delivery. Tenofovir is the generic name most often used in this setting because of its safety record. Whether to start, and whether to continue afterward, is a decision for the obstetric and liver teams together.

Breastfeeding is safe. The CDC is clear that hepatitis B is not transmitted through breast milk, and that a baby who has received the birth-dose vaccine and immune globulin can breastfeed normally. Cracked, bleeding nipples are the one situation where a lactation consultant’s advice is useful.

For families where a child already has chronic hepatitis B, the message is the same as for adults: monitoring, vaccination of siblings and parents, no restriction on school, sport, sleepovers or shared meals. Children rarely need treatment early on, because their immune systems tend not to attack the virus for many years. Pediatric liver specialists set the schedule, and decisions about when, or whether, to treat rest with them.

What people often get wrong about chronic hepatitis B

Misinformation about hepatitis B tends to be old, inherited and sticky. A few corrections that come up in almost every clinic:

“I feel fine, so my liver must be fine.” Feeling well says almost nothing about liver inflammation or scarring. Mayo Clinic and the NHS both stress that chronic hepatitis B is typically silent until advanced. Blood tests and scans are the only reliable readout.

“If I’m not on treatment, I’m not being treated properly.” Watchful monitoring is a guideline-endorsed strategy for people in quiet phases. Starting antivirals before they are indicated adds years of tablets without adding benefit.

“I can catch it or pass it on by sharing food.” No. Transmission requires blood or sexual fluids. Eating from the same plate, drinking from the same glass and kissing are not routes, per the CDC.

“A liver cleanse or herbal remedy will clear the virus.” No supplement or herbal product has been shown to clear hepatitis B, and several are documented causes of liver injury in the NIH’s drug-induced liver injury records. The claim is not merely unproven; some of these products make the problem worse.

“Antivirals are a short course, like antibiotics.” Hepatitis B antivirals suppress the virus while they are taken. Most people stay on them for years, and stopping abruptly can trigger a dangerous flare. Any change belongs to the prescribing clinician.

“Once my viral load is undetectable, I no longer need scans.” Liver cancer risk falls with suppression but does not disappear, particularly for people with cirrhosis or a family history. Surveillance scans continue.

“I’ll be excluded from my job or from having children.” Neither is true for the overwhelming majority of people. Occupational rules apply to a narrow set of exposure-prone roles, and pregnancy is managed routinely with a well-tested plan for the baby.

The thread running through these myths is a mismatch between how hepatitis B feels, which is usually like nothing, and how it behaves, which is slow and measurable. Trust the measurements.

Questions to ask your care team about living with chronic hepatitis B

A liver appointment can feel short and dense. Walking in with a written list changes the conversation, and the questions below are ones clinicians generally welcome because they show engagement rather than doubt.

• Which phase of hepatitis B am I in right now, and what would tell you it has changed?
• What are my current HBV DNA and ALT results, and what range are you hoping to see them in?
• Do I have any liver scarring, how was that measured, and when will it be measured again?
• Have I been tested for hepatitis C, hepatitis D and HIV, and am I immune to hepatitis A? If not, should I be vaccinated?
• Do I need liver cancer surveillance scans, and if so how often?
• Am I a candidate for antiviral treatment now? If not, what would change that?
• If I do start treatment, how long should I expect to be on it, what side effects should I watch for, and what happens if I miss doses or run out?
• What is your advice on alcohol for me specifically, given my results?
• Do any of my other medicines or supplements need reviewing for liver safety?
• Who in my household should be tested and vaccinated, and how do we arrange that?
• If I am planning a pregnancy, what would the plan look like?
• What symptoms should prompt me to call before my next appointment, and what number do I call?
• How will I receive results between visits, and what should I do if I do not hear back?

Two further questions are less clinical but just as legitimate. Ask whether a hepatitis nurse, pharmacist or patient organization is available for questions between visits. And ask, plainly, how the team would like you to raise mental health concerns, since anxiety and low mood are common after a chronic diagnosis and respond to support. A team that answers these clearly is a team you can build years of monitoring around.

When to call your doctor: red-flag signs with chronic hepatitis B

Most of life with chronic hepatitis B is uneventful, which makes it easy to forget that a small number of changes need a prompt call rather than a wait for the next scheduled visit. The list below is about acting early, not about self-diagnosis; the same signs have other causes, and the treating team is the right place to sort them out.

Contact your care team promptly, the same day if possible, for any of the following:

• Yellowing of the skin or the whites of the eyes, which signals a rise in bilirubin from a struggling liver
• Dark, tea-colored urine or pale, clay-colored stools
• New or worsening swelling of the abdomen or ankles
• Unexplained bruising, bleeding gums or nosebleeds that are hard to stop
• Persistent nausea, vomiting or loss of appetite with fatigue that is out of character
• Pain or a new sense of fullness under the right ribs
• Fever with any of the above
• Having stopped, or run out of, hepatitis B antivirals for more than a few days, since withdrawal can provoke a flare that needs monitoring

Seek emergency care immediately for vomiting blood, passing black or tar-like stools, sudden confusion, unusual drowsiness or difficulty staying awake, or severe abdominal pain with a rigid abdomen. These can indicate bleeding from swollen veins in the food pipe, a build-up of toxins the liver is no longer clearing, or infection of abdominal fluid, all of which are treatable and time-sensitive.

Also reach out, without urgency but without delay, if you have started any new prescription, over-the-counter drug or supplement, if you are planning a pregnancy, if you have been told you need chemotherapy, steroids or other immune-suppressing treatment for another condition, or if you have simply lost track of when your last check-up was. Reactivation of hepatitis B during immunosuppression is a known risk, and letting every clinician involved know your status is one of the most protective things you can do.

Every decision about testing, treatment and follow-up sits with your treating team. What sits with you is the phone call.

Frequently asked questions

How long can I live with hepatitis B?

There is no single figure, because outcome depends on liver scarring at diagnosis, whether the virus is controlled, whether liver cancer surveillance is in place, and accelerants such as alcohol, fatty liver and hepatitis D. People who are monitored, treated when guidelines indicate and who avoid these accelerants are described by the NHS and CDC as managing a long-term condition rather than one that shortens life. Ask your team where you sit on each of those factors.

What foods should someone with hepatitis B eat?

No special hepatitis B diet exists. A balanced pattern rich in vegetables, whole grains, legumes, fish and unsaturated fats, with limited sugary drinks and ultra-processed food, protects the liver mainly by preventing fatty liver disease, which compounds scarring. Avoid raw shellfish because of Vibrio infection risk in liver disease, and check every herbal supplement with your team, since several are documented causes of liver injury.

How bad is chronic hepatitis B?

It ranges from a lifelong quiet infection with no liver damage to cirrhosis and liver cancer. The CDC estimates that 15% to 25% of people with unrecognized, unmanaged chronic infection develop serious liver disease over their lifetime, meaning most do not, and those who do are often people never tested or monitored. Symptoms are a poor guide because the condition is usually silent until advanced, so regular blood tests and scans determine how it unfolds.

What are the most common causes of chronic hepatitis?

Worldwide, hepatitis B and hepatitis C viruses are the leading causes of chronic hepatitis, followed by alcohol-related liver disease and metabolic dysfunction-associated steatotic liver disease linked to weight and insulin resistance. Less common causes include autoimmune hepatitis, certain medicines and inherited conditions such as hemochromatosis. Several causes can coexist, and hepatitis B combined with alcohol or fatty liver scars the liver faster than any one alone.

Can I drink alcohol at all with hepatitis B and alcohol-related risk in mind?

The NHS, Mayo Clinic and CDC advise people with hepatitis B to avoid alcohol. Heavy drinking clearly accelerates cirrhosis and liver cancer; the data on light, occasional drinking are weaker, which is not the same as showing it is safe. Anyone with cirrhosis or raised liver enzymes is generally told to abstain completely. For others, the conversation is individual, and the safest choice remains none.

Can hepatitis B be treated, and does chronic hepatitis B treatment last forever?

Yes, chronic hepatitis B is treatable. Nucleos(t)ide analogue tablets block viral replication and suppress the virus in most people who take them consistently, lowering the risk of scarring and liver cancer. They control rather than remove the virus, so most people remain on them for years and often indefinitely. Whether to start, and whether to ever stop, is decided by the prescribing clinician based on viral levels, liver enzymes and scarring.

Is hepatitis B life expectancy shorter if I am not on medication?

Not necessarily. Many people are in a phase where the virus is present but the liver is not inflamed, and guidelines support monitoring rather than treating them. What shortens life is unrecognized inflammation, untreated scarring and late-detected liver cancer, all of which regular check-ups are designed to catch. Someone monitored every six to twelve months without medication may be in a better position than someone on tablets who skips follow-up.

Do I have to tell my employer I have hepatitis B?

In most jobs, no. Hepatitis B is not spread by casual workplace contact, and the CDC notes that chronic hepatitis B is generally protected under US federal disability discrimination law. Exceptions are exposure-prone healthcare roles, where occupational health services, not managers, review status confidentially and typically allow continued practice with monitoring. Rules differ by country, so anyone in such a role should consult their occupational health department.

Can I have children if I have chronic hepatitis B?

Yes. Pregnancy is routinely managed, and transmission to the baby is preventable. Newborns receive a hepatitis B vaccine dose and hepatitis B immune globulin within hours of birth, followed by the full vaccine series and a confirmatory blood test. For people with very high viral levels, clinicians may discuss an antiviral in later pregnancy. Breastfeeding is safe once the baby has received the birth-dose protection, according to the CDC.

Can I exercise and play contact sports with hepatitis B?

Yes, without restriction in any major guideline. Exercise does not affect viral activity and helps reduce liver fat and cardiovascular risk. In contact sports, follow standard blood rules: cover cuts, do not share towels or razors, and leave the field to dress any bleeding wound. Scale back during an acute flare with heavy fatigue, and ask your team about high-impact activity if you have cirrhosis.

References

• World Health Organization – Hepatitis B fact sheet
• CDC – About Hepatitis B
• NHS – Hepatitis B
• NIH NIDDK – Hepatitis B

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.